Günter Schwalm

Title: Günter Schwalm: Innovator in Pharmaceutical Chemistry

Introduction

Günter Schwalm is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Günter Schwalm holds a patent for Pyrrolidone carboxamides. This patent describes Pyrrolidone carboxamides of formula (I), where R represents a group of formula (a) or (b), and R can be phenyl, heteroalkyl, aryloxy, alkoxy, alkanoyl, or —NRR. The compounds are designed to inhibit the interaction of neuropeptide Y (NPY) with one of the neuropeptide receptor subtypes (NPY-Y5). They are particularly suitable for the prevention and treatment of conditions such as arthritis, diabetes, eating disorders, and obesity. The compounds can be produced by known methods and converted into a galenic dosage form.

Career Highlights

Günter Schwalm is associated with Actelion Pharmaceuticals Ltd., where he has contributed to various innovative projects. His work has led to advancements in the pharmaceutical industry, particularly in the development of new therapeutic agents.

Collaborations

Throughout his career, Günter has collaborated with notable colleagues, including Markus Isler and Thomas Giller. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Günter Schwalm's contributions to pharmaceutical chemistry, particularly through his patent on Pyrrolidone carboxamides, highlight his role as an innovator in the industry. His work continues to influence the development of treatments for various health conditions.